1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Sepsis Diagnostics Market
2.2. Global Sepsis Diagnostics Market, By Product, 2023 (US$ Million)
2.3. Global Sepsis Diagnostics Market, By Technology, 2023 (US$ Million)
2.4. Global Sepsis Diagnostics Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023

3. Sepsis Diagnostics Market: Competitive Analysis
3.1. Market Positioning of Key Sepsis Diagnostics Market Vendors
3.2. Strategies Adopted by Sepsis Diagnostics Market Vendors
3.3. Key Industry Strategies
4. Sepsis Diagnostics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Sepsis Diagnostics Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Blood Culture Media
5.3.2. Assay Kits and Reagents
5.3.3. Instruments

6. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Microbiology
6.3.2. Molecular Diagnostics
6.3.3. Immunoassays
6.3.4. Flow Cytometry


7. North America Sepsis Diagnostics Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
7.3. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)
7.4.Sepsis Diagnostics Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
7.4.1.1.2. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
7.4.1.2.2. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
7.4.1.3.2. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)

8. UK and European Union Sepsis Diagnostics Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
8.3. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)
8.4.Sepsis Diagnostics Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
8.4.1.1.2. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
8.4.1.2.2. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
8.4.1.3.2. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
8.4.1.4.2. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
8.4.1.5.2. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
8.4.1.6.2. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)

9. Asia Pacific Sepsis Diagnostics Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
9.3. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)
9.4.Sepsis Diagnostics Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
9.4.1.1.2. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
9.4.1.2.2. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
9.4.1.3.2. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
9.4.1.4.2. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
9.4.1.5.2. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
9.4.1.6.2. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)

10. Latin America Sepsis Diagnostics Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
10.3. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)
10.4.Sepsis Diagnostics Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
10.4.1.1.2. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
10.4.1.2.2. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
10.4.1.3.2. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)

11. Middle East and Africa Sepsis Diagnostics Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
11.3. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)
11.4.Sepsis Diagnostics Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
11.4.1.1.2. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
11.4.1.2.2. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Sepsis Diagnostics Market: By Product, 2022-2032, USD (Million)
11.4.1.3.2. Sepsis Diagnostics Market: By Technology, 2022-2032, USD (Million)

12. Company Profile
12.1. Abbott Laboratories, Inc.
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Becton, Dickinson and Company
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Biomerieux, Inc.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Bruker Corporation
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Cepheid, Inc.
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Immunexpress, Inc.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Nanosphere, Inc. (A Luminex Company)
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Roche Diagnostics Limited (A Subsidiary of F. Hoffmann-La Roche Ltd.)
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. T2 Biosystems, Inc.
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Thermo Fisher Scientific, Inc.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives